Skip to main content

Table 5 Risk factors for in-hospital mortality following AE in patients with fibrotic HP

From: Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes

Characteristics

Unadjusted model

Odds ratio (95% CI)

P-value

Age

0.998 (0.922–1.081)

0.964

Female sex

4.500 (0.585–34.608)

0.148

BMI

0.969 (0.763–1.230)

0.793

Ever smoker

0.333 (0.044–2.523)

0.287

Fever

0.500 (0.065–3.845)

0.505

Purulent sputum

5.400 (0.437–66.671)

0.188

PaO2/FiO2

0.983 (0.967–0.999)

0.040

CRP

1.070 (0.959–1.194)

0.229

FVC*

0.982 (0.935–1.032)

0.474

DLCO*

0.983 (0.931–1.038)

0.537

  1. Presented data are the values at the time of AE
  2. AE acute exacerbation, BMI body mass index, CI confidence interval, CRP C-reactive protein, DLCO diffusing capacity of the lung for carbon monoxide, FiO2 fraction of inspired oxygen, FVC forced vital capacity, HP hypersensitivity pneumonitis, PaO2 Partial pressure of oxygen
  3. *Presented data are closest measured values before AE (median interval: 3.0 months)